Center For Scientific Review; Notice of Closed Meeting, 26069 [2018-11956]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 108 / Tuesday, June 5, 2018 / Notices
Time: June 22, 2017, 8:00 a.m. to 3:00 p.m.
Agenda: Evaluate sleep and circadian
research activities; discuss plans for the
proposed revision of the NIH Sleep Disorders
Research Plan, and potential opportunities
for the inter-agency coordination activities.
Place: National Institutes of Health, Two
Rockledge Center, Conference Room 9100–
9104, 6701 Rockledge Drive, Bethesda, MD
20892.
Contact Person: Michael J. Twery, Ph.D.,
Director, National Center on Sleep Disorders
Research, Division of Lung Diseases, National
Heart, Lung, and Blood Institute, National
Institutes of Health, 6701 Rockledge Drive,
Suite 10170, Bethesda, MD 20892–7952, 301–
435–0199, twerym@nhlbi.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/about/committees/sdrab/,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 30, 2018.
Michelle D. Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–11959 Filed 6–4–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meeting
amozie on DSK3GDR082PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cancer Drug Development and
Therapeutics.
Date: June 18–19, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
VerDate Sep<11>2014
20:19 Jun 04, 2018
Jkt 241001
Contact Person: Lilia Topol, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–451–
0131, ltopol@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 30, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–11956 Filed 6–4–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
joint meeting of the National Cancer
Advisory Board (NCAB) and NCI Board
of Scientific Advisors (BSA).
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov).
A portion of the National Cancer
Advisory Board meeting will be closed
to the public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Advisory Board; Ad Hoc Subcommittee on
Population Science, Epidemiology and
Disparities.
Open: June 25, 2018, 5:30 p.m. to 7:00 p.m.
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
26069
Agenda: Discussion on Population Science,
Epidemiology and Disparities.
Place: Gaithersburg Marriott
Washingtonian Center, Room—To Be
Determined, 9751 Washington Boulevard,
Gaithersburg, MD 20878.
Contact Person: Dr. Deborah Winn,
Executive Secretary, NCAB Ad Hoc
Subcommittee on Population Science,
Epidemiology and Disparities, National
Cancer Institute—Shady Grove, National
Institutes of Health, 9609 Medical Center
Drive, Room 4E344, Bethesda, MD 20892,
(240) 276–6755, winnde@mail.nih.gov.
Name of Committee: National Cancer
Advisory Board; Ad Hoc Subcommittee on
Global Cancer Research.
Open: June 25, 2018, 7:30 p.m. to 9:00 p.m.
Agenda: Discussion on Global Cancer
Research.
Place: Gaithersburg Marriott
Washingtonian Center, Room—To Be
Determined, 9751 Washington Boulevard,
Gaithersburg, MD 20878.
Contact Person: Dr. Edward Trimble,
Executive Secretary, NCAB Ad Hoc
Subcommittee on Global Cancer Research,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, Room 3W562, Bethesda, MD
20892, (240) 276–5796, trimblet@
mail.nih.gov.
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Open: June 26, 2018, 8:30 a.m. to 5:00 p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board and NCI Board of
Scientific Advisors, NCI Director’s report and
presentations, NCI Board of Scientific
Advisors Concepts Review.
Closed: June 26, 2018, 5:00 p.m. to 6:00
p.m.
Agenda: Review of NCAB grant
applications.
Place: National Cancer Institute—Shady
Grove 9609, Medical Center Drive, Room
TE406 & 408 Rockville, MD 20850.
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, Room 7W444, Bethesda, MD
20892, 240–276–6340, grayp@mail.nih.gov.
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Open: June 27, 2018, 9:00 a.m. to 12:00
p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board and NCI Board of
Scientific Advisors, NCI Board of Scientific
Advisors Concepts Review.
Place: National Cancer Institute—Shady
Grove 9609 Medical Center Drive, Room
TE406 & 408 Rockville, MD 20850.
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, Room 7W444, Bethesda, MD
20892, grayp@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
E:\FR\FM\05JNN1.SGM
05JNN1
]]>Agencies
[Federal Register Volume 83, Number 108 (Tuesday, June 5, 2018)]
[Notices]
[Page 26069]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-11956]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Cancer Drug Development and Therapeutics.
Date: June 18-19, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Lilia Topol, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-451-
0131, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 30, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-11956 Filed 6-4-18; 8:45 am]
BILLING CODE 4140-01-P
